Spots Global Cancer Trial Database for ixabepilone
Every month we try and update this database with for ixabepilone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | NCT01375829 | Adult Solid Neo... | Ixabepilone Pharmacological... Temsirolimus | 18 Years - | National Cancer Institute (NCI) | |
| Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons | NCT00627978 | Metastatic Brea... | ixabepilone | 18 Years - | Weill Medical College of Cornell University | |
| A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer | NCT00672009 | Prostatic Disea... Genital Neoplas... Urogenital Neop... Genital Disease... Adenocarcinoma Prostatic Neopl... Neoplasms, Glan... Carcinoma | Ixabepilone | - | Cedars-Sinai Medical Center | |
| BMS-247550 in Treating Patients With Stage IV Melanoma | NCT00036764 | Recurrent Melan... Stage IV Melano... | ixabepilone pharmacogenomic... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers | NCT00798252 | Advanced Cancer | Capecitabine Doxorubicin Ixabepilone Docetaxel Paclitaxel Brivanib alanin... | 18 Years - 75 Years | Bristol-Myers Squibb | |
| BMS-247550 in Treating Patients With Advanced Pancreatic Cancer | NCT00016965 | Pancreatic Canc... | ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT) | NCT00790894 | Metastatic Brea... | ixabepilone ixabepilone | 18 Years - 75 Years | Hellenic Cooperative Oncology Group | |
| Study of Pazopanib and Ixabepilone in Patients With Solid Tumors | NCT01012362 | Breast Cancer Lung Cancer Colon Cancer Pancreatic Canc... Head and Neck C... Kidney Cancer Sarcoma Hepatocellular ... | Pazopanib Ixabepilone | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| BMS-247550 in Treating Patients With Liver or Gallbladder Cancer | NCT00023946 | Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga... | ixabepilone laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer | NCT00998738 | Neuropathy Pain Recurrent Breas... Stage IV Breast... | Calcium Glucona... Magnesium Sulfa... Placebo Quality-of-Life... Questionnaire A... Ixabepilone | 18 Years - | Mayo Clinic | |
| Ixabepilone to Treat Cervical Cancer | NCT00924066 | Cervical Carcin... Cervical Adenoc... Cervical Adenos... Cervical Carcin... | Ixempra (Ixabep... | 18 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane Resistant | NCT01019577 | Metastatic Brea... | Ixabepilone | 20 Years - | R-Pharm | |
| Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer | NCT01168232 | Recurrent Uteri... Uterine Carcino... | Ixabepilone Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| BMS-247550 in Treating Patients With Stage IV Melanoma | NCT00036764 | Recurrent Melan... Stage IV Melano... | ixabepilone pharmacogenomic... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| BMS 247550 to Treat Kidney Cancer | NCT00030992 | Renal Cell Carc... | BMS-247550 Ranitidine Diphenhydramine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer | NCT00383149 | Metastatic Panc... | Ixabepilone Cetuximab | 18 Years - | R-Pharm | |
| BMS-247550 in Treating Women With Metastatic Breast Cancer | NCT00020904 | Breast Cancer | ixabepilone | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| BMS-247550 in Treating Patients With Metastatic Colorectal Cancer | NCT00033306 | Colorectal Canc... | ixabepilone Fluoropyrimidin... Irinotecan | 18 Years - | University of Alabama at Birmingham | |
| BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy | NCT00017056 | Esophageal Canc... Gastric Cancer | ixabepilone | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00022542 | Recurrent Adult... Stage III Adult... Stage IV Adult ... | ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer | NCT00207090 | Advanced Solid ... Neoplasms | ixabepilone Rifampin | 18 Years - | R-Pharm | |
| A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer | NCT00568022 | Breast Cancer | Ixabepilone Capecitabine | 20 Years - | R-Pharm | |
| Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer | NCT01084057 | Male Breast Can... Recurrent Breas... Stage IV Breast... | vorinostat ixabepilone laboratory biom... pharmacological... | 18 Years - | City of Hope Medical Center | |
| BMS-247550 in Treating Women With Metastatic Breast Cancer | NCT00020904 | Breast Cancer | ixabepilone | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer | NCT00045097 | Breast Cancer | ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies | NCT00207129 | Advanced Solid ... Neoplasms | Ixabepilone Capecitabine | 18 Years - | R-Pharm | |
| Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors | NCT00096317 | Unspecified Adu... | ixabepilone ketoconazole | 18 Years - 120 Years | Montefiore Medical Center | |
| BMS-247550 in Treating Women With Metastatic Breast Cancer | NCT00020904 | Breast Cancer | ixabepilone | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Ixabepilone Administered as an Enteric Coated Formulation. | NCT00309049 | Cancer | Ixabepilone Ixabepilone Ixabepilone | 18 Years - | R-Pharm | |
| BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors | NCT00028561 | Unspecified Adu... | ixabepilone carboplatin laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery | NCT01079793 | Prostate Cancer | ixabepilone adjuvant therap... intensity-modul... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer | NCT00825734 | Metastatic Brea... | Sorafenib Ixabepilone | 18 Years - | SCRI Development Innovations, LLC | |
| Phase I Combination w/ Epirubicin | NCT00322374 | Metastatic Brea... | Ixabepilone Epirubicin | 18 Years - | R-Pharm | |
| Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer | NCT00030706 | Ovarian Cancer Peritoneal Cavi... | ixabepilone | 18 Years - 75 Years | Montefiore Medical Center | |
| Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer | NCT00207090 | Advanced Solid ... Neoplasms | ixabepilone Rifampin | 18 Years - | R-Pharm | |
| Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer | NCT00021099 | Distal Urethral... Metastatic Tran... Proximal Urethr... Recurrent Bladd... Recurrent Trans... Recurrent Ureth... Regional Transi... Stage III Bladd... Stage IV Bladde... Transitional Ce... Urethral Cancer... | ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine | NCT02915744 | Metastasis Breast Cancer | NKTR-102 Eribulin Ixabepilone Vinorelbine Gemcitabine Paclitaxel Docetaxel Nab-paclitaxel | 18 Years - | Nektar Therapeutics | |
| Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer | NCT00079326 | HER2-positive B... Recurrent Breas... Stage IV Breast... | trastuzumab ixabepilone laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer | NCT00998738 | Neuropathy Pain Recurrent Breas... Stage IV Breast... | Calcium Glucona... Magnesium Sulfa... Placebo Quality-of-Life... Questionnaire A... Ixabepilone | 18 Years - | Mayo Clinic | |
| BMS-247550 in Treating Patients With Liver or Gallbladder Cancer | NCT00023946 | Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga... | ixabepilone laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| BMS 247550 to Treat Kidney Cancer | NCT00030992 | Renal Cell Carc... | BMS-247550 Ranitidine Diphenhydramine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy | NCT00017043 | Esophageal Canc... Gastric Cancer | ixabepilone | 18 Years - | Bristol-Myers Squibb | |
| BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | NCT00004927 | Unspecified Adu... | ixabepilone | 18 Years - 120 Years | R-Pharm | |
| Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy | NCT00998101 | Lung Cancer | cetuximab carboplatin ixabepilone | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma | NCT00058019 | Anaplastic Larg... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Mantl... | ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| Study of Ixabepilone (BMS-247550) in Patients With Solid Tumors | NCT01018966 | Solid Tumors | Ixabepilone | 20 Years - 75 Years | R-Pharm | |
| A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma | NCT01454479 | Recurrent Endom... | Lapatinib and i... | 20 Years - 75 Years | Chang Gung Memorial Hospital | |
| Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy | NCT00998101 | Lung Cancer | cetuximab carboplatin ixabepilone | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy | NCT00998101 | Lung Cancer | cetuximab carboplatin ixabepilone | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer | NCT00923130 | Renal Cell Carc... | Bevacizumab Ixabepilone | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Phase I Combination w/ Epirubicin | NCT00322374 | Metastatic Brea... | Ixabepilone Epirubicin | 18 Years - | R-Pharm | |
| A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline | NCT01027208 | Metastatic Brea... | Ixabepilone | 20 Years - | R-Pharm | |
| Ixabepilone and Pemetrexed/Solid Tumors | NCT01170871 | Advanced Solid ... | Ixabepilone Pemetrexed | 18 Years - | University of Southern California | |
| Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer | NCT00593827 | Metastatic Brea... | Ixabepilone Ixabepilone | 18 Years - | R-Pharm | |
| Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors | NCT00070096 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | ixabepilone | 16 Years - | National Cancer Institute (NCI) | |
| Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer | NCT00455533 | Breast Cancer | Ixabepilone Paclitaxel Cyclophosphamid... Doxorubicin | 18 Years - | Bristol-Myers Squibb | |
| Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer | NCT00983801 | Stomach Neoplas... | Ixabepilone | 18 Years - | R-Pharm | |
| Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma | NCT00058019 | Anaplastic Larg... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Mantl... | ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer | NCT00789581 | Breast Cancer | Doxorubicin Cyclophosphamid... Ixabepilone (Ix... Paclitaxel (Tax... | 18 Years - | SCRI Development Innovations, LLC | |
| BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors | NCT00043095 | Unspecified Adu... | gemcitabine hyd... ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer | NCT00049244 | Breast Cancer | capecitabine ixabepilone | 18 Years - 120 Years | R-Pharm | |
| Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer | NCT00923130 | Renal Cell Carc... | Bevacizumab Ixabepilone | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors | NCT00028561 | Unspecified Adu... | ixabepilone carboplatin laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Ixabepilone and SBRT For Metastatic Breast Cancer | NCT01818999 | METASTATIC BREA... | IXABEPILONE STEREOTACTIC BO... | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
| Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer | NCT00866905 | Breast Cancer | Ixabepilone Cyclophosphamid... | 18 Years - | SCRI Development Innovations, LLC | |
| Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer | NCT00983801 | Stomach Neoplas... | Ixabepilone | 18 Years - | R-Pharm | |
| A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine | NCT02915744 | Metastasis Breast Cancer | NKTR-102 Eribulin Ixabepilone Vinorelbine Gemcitabine Paclitaxel Docetaxel Nab-paclitaxel | 18 Years - | Nektar Therapeutics | |
| A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas | NCT00045708 | Adult Anaplasti... Adult Giant Cel... Adult Gliosarco... Recurrent Adult... | ixabepilone pharmacological... Anticonvulsant | 18 Years - | National Cancer Institute (NCI) | |
| A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma | NCT01454479 | Recurrent Endom... | Lapatinib and i... | 20 Years - 75 Years | Chang Gung Memorial Hospital | |
| Neo-Adjuvant Study in Triple Negative Breast Cancer Patients | NCT01097642 | Breast Cancer | Cetuximab Ixabepilone | 18 Years - | The Methodist Hospital Research Institute | |
| BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors | NCT00043095 | Unspecified Adu... | gemcitabine hyd... ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer | NCT00828308 | Prostate Cancer | Ixabepilone Prostatectomy | 18 Years - | Brown University | |
| Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck | NCT00033618 | Metastatic Squa... Recurrent Metas... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Salivary Gland ... Stage IV Squamo... Stage IVA Saliv... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVA Verru... Stage IVB Saliv... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Stage IVB Verru... Stage IVC Saliv... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Verru... Stage IVC Verru... Tongue Cancer | ixabepilone laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer | NCT00828308 | Prostate Cancer | Ixabepilone Prostatectomy | 18 Years - | Brown University | |
| Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies. | NCT00162136 | Solid Malignanc... | Ixabepilone | 18 Years - | R-Pharm | |
| Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies | NCT00207129 | Advanced Solid ... Neoplasms | Ixabepilone Capecitabine | 18 Years - | R-Pharm | |
| Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer | NCT00765765 | Breast Cancer | hydroxychloroqu... ixabepilone | 18 Years - 120 Years | Rutgers, The State University of New Jersey | |
| Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC) | NCT00080262 | Breast Cancer Metastases | Ixabepilone | 18 Years - | R-Pharm | |
| Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | NCT01375829 | Adult Solid Neo... | Ixabepilone Pharmacological... Temsirolimus | 18 Years - | National Cancer Institute (NCI) | |
| Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer | NCT00077376 | HER2-positive B... Male Breast Can... Recurrent Breas... Stage IV Breast... | trastuzumab ixabepilone carboplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
